Welcome to our dedicated page for SYNOPSYS SEC filings (Ticker: SNPS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Synopsys Inc. filings document the regulatory record for a Nasdaq-listed engineering software company whose common stock trades under SNPS. The company’s disclosures cover operating and financial results, capital allocation actions such as stock repurchase authorizations and accelerated share repurchase agreements, and material-event reports tied to governance, executive roles, and organizational changes.
Proxy and annual meeting materials describe board elections, shareholder voting matters, executive compensation, equity incentive plan approvals, and corporate governance practices. Recent Form 8-K filings also document restructuring actions following the completed Ansys acquisition, amendments to prior governance disclosures, registered common stock details, exhibits, and risk-oriented statements associated with forward-looking business actions.
Sudhindra Kankanwadi, Chief Accounting Officer of Synopsys, reported option exercises and share sales in two transactions on September 19 and September 22, 2025. On September 19 he exercised 6,000 non-qualified stock options with an exercise price of $89.76 and sold 6,000 shares (sale price listed as $482). On September 22 he exercised 9,873 options at $89.76 and sold 9,873 shares at a weighted average reported sale price in the filing of $500.90 to $501.04. Following these reported transactions the filing shows he beneficially owns 20,520 shares of Synopsys common stock. The form was signed by POA Liz Ramirez for Mr. Kankanwadi on September 23, 2025.
Form 144 filed for Synopsys, Inc. (SNPS) reports a proposed sale of 9,873 common shares to be executed through Morgan Stanley Smith Barney on 09/22/2025, with an aggregate market value of $4,945,407.42. The filer acquired these shares on 09/22/2025 by exercising stock options and paid in cash. The filing also discloses a prior sale by Sudhindra Kankanwadi of 6,000 shares on 09/19/2025 for $2,892,000.00. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Synopsys, Inc. (SNPS) notice reports a proposed sale under Rule 144 of 6,000 common shares via Morgan Stanley Smith Barney LLC on 09/19/2025 with an aggregate market value of $2,892,000.00. The shares were acquired the same day through a stock option exercise and paid in cash. The filing states there were no other securities sold by the reporting person in the prior three months and includes the standard representation that the seller has no undisclosed material adverse information about the issuer.
Synopsys, Inc. filed an amendment to a current report to expand its prior disclosure about board changes. The filing confirms that on July 17, 2025, the board appointed Mr. Vijayaraghavan as a director. It further clarifies that, effective September 17, 2025, he was also appointed to the Corporate Governance and Nominating Committee of the board. No other aspects of the earlier report were revised, so this update is limited to committee responsibilities for the new director.
Robert G. Painter, a director of Synopsys, acquired 350 shares of Synopsys Inc. common stock on 09/11/2025 at a reported price of $425.4397 per share. After the purchase, Mr. Painter beneficially owned 2,291 shares directly.
The Form 4 was filed as a single reporting person filing and the form bears a signature by power of attorney, Liz Ramirez, on behalf of Mr. Painter dated 09/15/2025. No derivative transactions or additional explanatory text are included.
Synopsys reported a transaction-heavy quarter driven by the completed acquisition of Ansys and related financing. The company closed the Ansys Merger on July 17, 2025 and included Ansys results prospectively. To fund the cash portion of the merger, Synopsys issued Senior Notes with approximately $9.9 billion net proceeds and borrowed the full $4.3 billion under a Term Loan. Synopsys recognized a $860.5 million pre-tax gain (net of adjustments) from the prior sale of its Software Integrity business and has $10.1 billion of contracted but unsatisfied performance obligations (backlog) as of July 31, 2025. The company recorded an unrealized $121.6 million loss from terminated interest rate locks that is being amortized to interest expense, suspended its $1.5 billion repurchase program with $194.3 million remaining, and reported material operational headwinds in its Design IP segment related to China export control developments.
Synopsys, Inc. filed a current report to let investors know it has released financial results for its third fiscal quarter ended July 31, 2025. The company announced these quarterly results in a press release dated September 9, 2025, which is attached to the report as Exhibit 99.1 and incorporated by reference. The report clarifies that this earnings information is being furnished rather than filed, which affects how it is treated under federal securities laws, and that it will only be included in other SEC documents if specifically referenced.
Shelagh Glaser, Chief Financial Officer of Synopsys, filed a Form 4 reporting option exercises and share transactions executed pursuant to a Rule 10b5-1 trading plan. The report shows transactions dated 09/05/2025 under a 10b5-1 plan adopted January 13, 2025. On that date Ms. Glaser acquired 2,612 shares via a $348.17-priced non-qualified option and 1,043 shares via a $354.45-priced non-qualified option. The Form also reports corresponding dispositions of 2,612 and 1,043 shares at $609.77. Beneficial ownership totals shown after the transactions include 17,929, 16,360 and 15,317 shares in various lines. The Form 4 was submitted by POA Liz Ramirez on 09/09/2025.
Form 144 notice for Synopsys, Inc. (SNPS) indicates a proposed sale of 3,655 shares of common stock through Morgan Stanley Smith Barney on 09/05/2025. The filing reports an aggregate market value of $2,228,709.35 and lists 155,160,938 shares outstanding. The securities were acquired on 09/05/2025 by stock option exercise and paid in cash on the same date. The filing also discloses a prior sale by Shelagh M Glaser of 7,310 shares on 06/06/2025 for $3,550,608.81. The form includes the seller's representation about absence of undisclosed material information.
Janet Lee, General Counsel and Corporate Secretary of Synopsys, reported transactions on 09/03/2025. The filing shows the vesting/conversion of 293 restricted stock units into common stock and related non-derivative entries. Following the reported activity, the filing lists beneficial ownership figures of 8,986 and 8,858 shares in two common-stock lines. The company retained a portion of shares to satisfy the reporting person’s tax-withholding obligations for the vested award, as disclosed by the reporting person.